Paula Traquina

737 total citations
11 papers, 482 citations indexed

About

Paula Traquina is a scholar working on Immunology, Epidemiology and Microbiology. According to data from OpenAlex, Paula Traquina has authored 11 papers receiving a total of 482 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Immunology, 3 papers in Epidemiology and 3 papers in Microbiology. Recurrent topics in Paula Traquina's work include Immune Response and Inflammation (4 papers), Antimicrobial Peptides and Activities (3 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Paula Traquina is often cited by papers focused on Immune Response and Inflammation (4 papers), Antimicrobial Peptides and Activities (3 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Paula Traquina collaborates with scholars based in United States, Taiwan and Austria. Paula Traquina's co-authors include Gary Van Nest, Marsha Wills‐Karp, Joanna Santeliz, Mario Contorni, Maurizio Morandi, Robert L. Coffman, John D. Campbell, Thomas E. Eessalu, B B Aggarwal and Luke Tzu-Chi Liu and has published in prestigious journals such as Journal of Biological Chemistry, Scientific Reports and Journal of Allergy and Clinical Immunology.

In The Last Decade

Paula Traquina

11 papers receiving 453 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Paula Traquina United States	9	249	118	111	104	87	11	482
Seishiro Naito Japan	15	281 1.1×	183 1.6×	56 0.5×	50 0.5×	114 1.3×	45	553
Jean Yves Bonnefoy France	7	370 1.5×	74 0.6×	34 0.3×	151 1.5×	63 0.7×	8	599
Cécile Schiffer France	8	349 1.4×	120 1.0×	58 0.5×	44 0.4×	53 0.6×	8	486
Karlheinz Enssle Germany	12	204 0.8×	40 0.3×	30 0.3×	123 1.2×	100 1.1×	18	426
Alena Egyed Austria	7	210 0.8×	130 1.1×	55 0.5×	23 0.2×	68 0.8×	8	409
Marcel L.C.M. Mevissen Netherlands	11	324 1.3×	86 0.7×	35 0.3×	32 0.3×	118 1.4×	15	516
Pierre Brawand Switzerland	8	774 3.1×	69 0.6×	63 0.6×	48 0.5×	172 2.0×	9	907
Michiko Shibano Japan	5	233 0.9×	81 0.7×	25 0.2×	46 0.4×	47 0.5×	6	370
J Yata Japan	9	192 0.8×	60 0.5×	45 0.4×	25 0.2×	74 0.9×	22	384
O Rojas-Espinosa Mexico	11	287 1.2×	108 0.9×	261 2.4×	27 0.3×	203 2.3×	54	569

Countries citing papers authored by Paula Traquina

Since Specialization

Citations

This map shows the geographic impact of Paula Traquina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paula Traquina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paula Traquina more than expected).

Fields of papers citing papers by Paula Traquina

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paula Traquina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paula Traquina. The network helps show where Paula Traquina may publish in the future.

Co-authorship network of co-authors of Paula Traquina

This figure shows the co-authorship network connecting the top 25 collaborators of Paula Traquina. A scholar is included among the top collaborators of Paula Traquina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paula Traquina. Paula Traquina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Strohmeier, Shirin, Fatima Amanat, John D. Campbell, et al.. (2022). A CpG 1018 adjuvanted neuraminidase vaccine provides robust protection from influenza virus challenge in mice. npj Vaccines. 7(1). 81–81. 16 indexed citations

Kuo, Tsun‐Yung, Chia-En Lien, Yi‐Jiun Lin, et al.. (2022). Hamsters Protected from SARS-CoV-2 Delta Variant Challenge after Two Doses of Adjuvanted SARS-CoV-2 Recombinant Spike Protein (S-2P) and One Dose of Beta S-2P. The Journal of Infectious Diseases. 226(9). 1562–1567. 2 indexed citations

Coffman, Robert L., John D. Campbell, Paula Traquina, et al.. (2020). Development of CpG-adjuvanted stable prefusion SARS-CoV-2 spike antigen as a subunit vaccine against COVID-19. Scientific Reports. 10(1). 20085–20085. 108 indexed citations

Renn, Alex, et al.. (2018). Preclinical development of the TLR9 agonist DV281 as an inhaled aerosolized immunotherapeutic for lung cancer: Pharmacological profile in mice, non-human primates, and human primary cells. International Immunopharmacology. 66. 296–308. 18 indexed citations

Jackson, Sam, Albert F. Candia, Stephen Delaney, et al.. (2017). First‐in‐Human Study With the Inhaled TLR9 Oligonucleotide Agonist AZD1419 Results in Interferon Responses in the Lung, and Is Safe and Well‐Tolerated. Clinical Pharmacology & Therapeutics. 104(2). 335–345. 22 indexed citations

Raja, Krishnaswami, et al.. (2007). One-Pot Synthesis, Purification, and Formulation of Bionanoparticle−CpG Oligodeoxynucleotide Hepatitis B Surface Antigen Conjugate Vaccine via Tangential Flow Filtration. Bioconjugate Chemistry. 18(2). 285–288. 6 indexed citations

Marshall, Jason D., et al.. (2007). Immunostimulatory DNA as a vaccine adjuvant. Expert Review of Vaccines. 6(5). 747–759. 40 indexed citations

Santeliz, Joanna, et al.. (2002). Amb a 1–linked CpG oligodeoxynucleotides reverse established airway hyperresponsiveness in a murine model of asthma. Journal of Allergy and Clinical Immunology. 109(3). 455–462. 131 indexed citations

Dairkee, Shanaz H., et al.. (1997). Partial enzymatic degradation of stroma allows enrichment and expansion of primary breast tumor cells.. PubMed. 57(8). 1590–6. 21 indexed citations

10.

Traquina, Paula, Maurizio Morandi, Mario Contorni, & Gary Van Nest. (1996). MF59 Adjuvant Enhances the Antibody Response to Recombinant Hepatitis B Surface Antigen Vaccine in Primates. The Journal of Infectious Diseases. 174(6). 1168–1175. 77 indexed citations

11.

Aggarwal, B B, Paula Traquina, & Thomas E. Eessalu. (1986). Modulation of receptors and cytotoxic response of tumor necrosis factor-alpha by various lectins.. Journal of Biological Chemistry. 261(29). 13652–13656. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact